TY  - GEN
AU  - Rajagopalan,Krithika
AU  - Bloudek,Lisa
AU  - Marvel,Jessica
AU  - Dembek,Carole
AU  - Kavati,Abhishek
TI  - Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
SN  - 1178-2005
PY  - 2019///0701
KW  - Administration, Inhalation
KW  - Adrenergic beta-2 Receptor Agonists
KW  - administration & dosage
KW  - Bronchodilator Agents
KW  - Cost-Benefit Analysis
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Drug Costs
KW  - Forced Expiratory Volume
KW  - Glycopyrrolate
KW  - Humans
KW  - Indans
KW  - Lung
KW  - drug effects
KW  - Markov Chains
KW  - Models, Economic
KW  - Muscarinic Antagonists
KW  - Nebulizers and Vaporizers
KW  - economics
KW  - Powders
KW  - Pulmonary Disease, Chronic Obstructive
KW  - diagnosis
KW  - Quinolones
KW  - Randomized Controlled Trials as Topic
KW  - Severity of Illness Index
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.2147/COPD.S177097
ER  -